Legal Basis and Authority
- The classification was made pursuant to Section 36(a) of Republic Act No. 6425, as amended (the Comprehensive Dangerous Drugs Act of 2002).
- The DDB exercises its regulatory powers to list and control dangerous drugs under its mandate.
Substance Classification Scheme
- The Regulation introduces a two-tier classification:
- Section I: Prohibited Drugs - substances completely banned from manufacture, distribution, and use except for approved scientific and medical purposes.
- Section II: Regulated Drugs - substances subjected to regulations that control their manufacture, distribution, and use under specified conditions.
Sanctions and Enforcement
- Violations of the Regulations serve as grounds for administrative actions against offenders, which may include suspension or revocation of licenses and other penalties.
- These administrative sanctions do not preclude the possibility of criminal prosecution if the violation warrants such action.
Effectivity of the Regulation
- The Regulation takes effect fifteen (15) days after publication in a newspaper of general circulation.
- Publication is required for two consecutive weeks to ensure public awareness and compliance.
Notable Provisions
- The Regulation explicitly includes salts and isomers of the listed substances to prevent circumvention of controls through chemical modifications.
- The institutional endorsement from the Secretary General of WHO underlines the international consensus on controlling these substances.
- The Regulation is signed and attested by high-ranking officials including the Undersecretary of Health, Chief of Staff, Vice-Chairman of the DDB, and the Executive Director, ensuring legal and administrative validity.